The Valley Desk

ArticleCancer cellPublished

EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Cancer cell
Published
Subject terms
T-Lymphocytes; Cell Line, Tumor; Animals; Humans; Mice; Neoplasms; Benzamides; Biphenyl Compounds; Morpholines; Pyridones; Immunotherapy, Adoptive; Xenograft Model Antitumor Assays
PubMed ID
39983725
PubMed Central ID
PMC13312562
Added to directory
Source checked

Report a correction or request removal